Close Menu
    What's Hot

    Measles outbreak in Bangladesh passes 60,000 cases

    May 23, 2026

    PM Modi and Meloni spotlight deepening India-Italy ties

    May 21, 2026

    UAE and Germany review strategic ties in Berlin

    May 21, 2026
    Facebook X (Twitter) Instagram
    Niger LiveNiger Live
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • More
      • Sports
      • Technology
      • Travel
    Niger LiveNiger Live
    Home » With an Eye on the Future, Biolog Launches Odin
    ACCESS Newswire

    With an Eye on the Future, Biolog Launches Odin

    June 15, 2023
    Facebook Twitter Pinterest Reddit Telegram LinkedIn Tumblr VKontakte WhatsApp Email

    HAYWARD, CA / ACCESSWIRE / June 15, 2023 / Biolog, Inc., a leading provider of microbial polyphasic analysis, today announced the launch of the Odin™ system, an all-in-one cellular phenotyping and microbial identification platform. Odin is compatible with all Biolog assays and is available now.

    Until today, Biolog’s OmniLog® platform was the gold standard for researchers who want actionable insights on microbial metabolic phenotypes. Odin now builds on that foundation while maintaining the core capabilities to incubate, analyze, and compare thousands of microbial and mammalian growth conditions in a single experiment, and to identify aerobic bacteria by its metabolic fingerprint.

    Odin changes up the detection method and uses Optical Density (OD), which enables a critical additional modality to measure cell growth. Now on a single platform, researchers can distinguish the effect of a substrate on growth (by OD) and by respiration using our proprietary dye, now an absorbance-based measurement. With the additional Odin capabilities, researchers can now decouple a microbe’s respiration rate from its division rate and more fully understand the metabolic output of a cell. With a fully loaded system, Odin records the OD for all conditions for up to 50 plates at a time, measuring the kinetics of cell growth and respiration for thousands of conditions in parallel.

    Odin also has broader identification capabilities, including anaerobes, yeast, and filamentous fungi. All told, Odin can identify thousands of microbes, allowing researchers to classify unknown organisms and phenotype them on the same platform.

    “We heard from our customers the need to directly measure growth. In a short time, we brought in additional scientific expertise, and built a product development engine. The customer-focused mindset and our dedicated teams have enabled us to quickly meet the needs of our customers,” said Robert Wicke, CEO of Biolog.

    “Understanding how microbes respond to their environment and food sources is the major economic driver in sustainable agriculture, bioprocessing and synthetic biology, to name just a few areas. We are enthusiastic about the foundation that Odin creates for Biolog and our customers,” said Mr. Wicke.

    About Biolog

    Biolog has the tools, services, and support to provide the microbial phenotypic characterization and polyphasic identification capabilities required to produce functionally relevant insights. Our products and services enable characterization of microbial and mammalian cells as well as identification of thousands of species of bacteria, yeast, and fungi. Learn more at www.biolog.com.

    Contact Information:

    John Proctor, Ph.D.
    CCO
    jproctor@biolog.com
    (408)306-0414

    SOURCE: Biolog Inc.

    .
    Share. Facebook Twitter Pinterest LinkedIn Reddit Email

    Related Posts

    AP Technologies Acquires Blueacre Technology, Adding Nitinol and Precision Laser Processing to Its Catheter Platform

    May 19, 2026

    Wellgistics Health Accelerates Digital Health Expansion of its Newly Announced RPM, RTM and CCM Pilot with Planned Acquisition of WellCare Today and its Proprietary Samsung Galaxy Watch Care Monitoring Program

    May 15, 2026

    Agnete Kirk Kristiansen Appointed Chair of the LEGO Foundation

    May 13, 2026

    Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services

    May 13, 2026
    Latest News

    Measles outbreak in Bangladesh passes 60,000 cases

    May 23, 2026

    PM Modi and Meloni spotlight deepening India-Italy ties

    May 21, 2026

    UAE and Germany review strategic ties in Berlin

    May 21, 2026
    © 2026 Niger Live | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.